Episode 30

full
Published on:

9th Feb 2026

30: Citric Acid Is Not What You Think - How Form Concentration and Context Change Everything with Dr. Rob Karlinsey and Tami

What if citric acid is not inherently good or bad, but misunderstood because formulation context is rarely explained?

In this episode of Dental Formulator’s Playbook, Dr. Rob and co-host Tami take a deep, science-first look at one of the most widely used yet misunderstood ingredients in modern products: citric acid. Building on earlier episodes that examined citric acid’s role in foods and dental erosion, this conversation explores how citric acid is made, why it appears in everything from toothpaste to skincare to cleaners, and how its chemistry changes depending on form, concentration, and context.

Dr. Rob explains the critical distinction between citric acid and citrate, why hydration state matters for formulators, and how citric acid functions as a buffer, chelator, preservative, and flavor modifier. The discussion traces citric acid’s industrial production back to early fermentation research, its historical link to penicillin scale-up through Pfizer, and its foundational role in cellular energy via the Krebs (citric acid) cycle. The episode also examines citric acid’s use in cosmetics as an alpha hydroxy acid, in household cleaners, in laboratory sample preservation, and in encapsulated food applications.

Rather than framing citric acid as “good” or “bad,” this episode emphasizes understanding concentration, buffering, formulation design, and intended use to make informed decisions across oral care, food, skincare, and consumer products.

Key Topics Covered

  1. The difference between citric acid and citrate in aqueous systems
  2. Why citric acid and sodium citrate behave the same once dissolved in water
  3. Hydration states of raw materials (anhydrous, monohydrate, dihydrate) and why they matter for formulation accuracy
  4. How citric acid functions as a buffer in pharmaceuticals and oral care products
  5. Why citric acid is considered a natural ingredient despite industrial-scale production
  6. Fermentation-based production of citric acid using Aspergillus niger
  7. The historical link between citric acid scale-up and penicillin mass production
  8. Pfizer’s role in advancing fermentation technology during World War II
  9. James Currie’s 1917 research and its lasting impact on microbial production methods
  10. Why fermentation is still the dominant method for producing citric acid today
  11. Citric acid’s role in metabolism through the Krebs (citric acid) cycle
  12. Alpha hydroxy acids (AHAs) and citric acid’s role in skincare formulations
  13. Concentration differences between dental products, foods, cosmetics, and cleaners
  14. Why buffering citric acid is critical in oral care and pharmaceutical products
  15. Citric acid use in household cleaners, including modern low-toxicity formulations
  16. Encapsulated citric acid in food applications and controlled-release systems
  17. Why formulation context matters more than ingredient labels alone

Highlights and Takeaways

  1. Citric acid and citrate are chemically linked and convert based on pH once dissolved
  2. Hydration state affects raw material weighing, not final function in solution
  3. Fermentation, not fruit extraction, is how citric acid is produced at scale
  4. Citric acid production enabled the industrial-scale manufacture of penicillin
  5. The same citric acid found in foods, like lemons, is chemically identical to that produced by fermentation
  6. Citric acid is central to cellular energy metabolism through the Krebs cycle
  7. In oral care and pharmaceuticals, citric acid must be buffered for stability and safety
  8. Concentration determines function, from gentle buffering to aggressive exfoliation
  9. Lack of testing, not citric acid itself, creates risk in consumer products
  10. Understanding chemistry allows better decisions across food, dental, skincare, and cleaning products

References

Fermentation of Citric Acid and Penicillin History

  1. https://cen.acs.org/articles/83/i25/Penicillin.html
  2. https://cen.acs.org/articles/86/i28/Pfizers-Penicillin-Landmark.html
  3. US Patent #540,267, Issued July 1, 1913; Inventor: Boleslas Zahorski
  4. https://www.sciencedirect.com/science/article/pii/S0021925818867084

Krebs (Citric Acid) Cycle

  1. https://link.springer.com/article/10.1186/s40694-018-0054-5

Alpha Hydroxy Acids (AHAs)

  1. https://cen.acs.org/business/specialty-chemicals/7-acids-safely-put-face/104/web/2026/01

Citric Acid Cleaning Formulations

  1. US Patent #12,203,051 B2, Issued Jan 21, 2025; Assignee: Clorox Company

Encapsulated Citric Acid in Food Applications

  1. US Patent Application 2010/0330247 A1 (Abandoned); Assignee: Mondelez

📲 Connect with Dr. Rob (Robert L. Karlinsey, PhD)

🌐 Website: customdentalformulations.com

Robert L. Karlinsey, PhD

Google Scholar Profile

Show artwork for Dental Formulator's Playbook

About the Podcast

Dental Formulator's Playbook
The Dental Formulator’s Playbook is where science meets strategy in the world of oral health innovation. Hosted by Dr. Rob Karlinsey, a seasoned dental researcher and independent formulator, this podcast is your behind-the-scenes pass to what really goes into creating cutting-edge dental products.

Whether you're a dentist, a dental brand, or just someone curious about how toothpaste, rinses, and other oral care products are developed, you'll find practical insights and real-world takeaways in every episode. Dr. Karlinsey keeps it straightforward and engaging—no fluff, just clear, thoughtful explanations based on years of experience in the lab and the industry.

This show is all about helping dental professionals and product developers think differently, make better decisions, and stay ahead of the curve. If you care about science, results, and doing things the right way, you're in the right place.

About your host

Profile picture for Robert Karlinsey

Robert Karlinsey

Dr. Robert L. Karlinsey is a scientist and formulator with almost 20 years’ experience in dental research. He earned a BS in Physics (University of Scranton) and PhD in Chemical Physics (Indiana University), with postdoctoral work in physical chemistry (Indiana University). As a visiting assistant research professor at the Indiana University School of Dentistry, his research led to an impactful encounter with Dr. George Stookey, and shortly thereafter, the formation of Indiana Nanotech, LLC (now known as Custom Dental Formulations, LLC), of which he spearheaded all research and small-scale manufacturing efforts. Dr. Karlinsey is the inventor of Nanotech’s functionalized tricalcium phosphate systems, which continue to help generate over $100MM in global product sales for a major dental manufacturer. As Principal Investigator, his work has received significant funding through Federal (National Institutes of Health), State (Indiana and Texas), and industry grants and contracts. His research in patented calcium phosphate technologies continue to help generate over $100MM in global product sales. Previously, Dr. Karlinsey has served as Chief Scientific Officer at Therametric Technologies, Inc, and adjunct professor of chemistry at the University of Indianapolis.

Dr. Karlinsey addresses clients’ needs in preventive and cosmetic dentistry, including fluoride- and fluoride-free remineralization, antiplaque/gum health, whitening systems, and more. He is actively involved in clinical and laboratory research designs and performance-backed, customized oral care formulation solutions. And, whenever possible, he favors natural, nature-derived, and/or sustainably sourced ingredients